tirzepatide and creatine + Tirzepatide: Muscle Loss Prevention π₯ BIG FLASH SALE is
Description
doi: Gao X, Hua X, Wang X, et al
It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia ( In the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg were compared to the GLP-1RA semaglutide (1 mg once weekly) in patients not well controlled in therapy only with metformin ( 1c ( The SURPASS-3 study was started to study the efficacy and safety of TZP versus basal insulin degludec in diabetic patients inadequately controlled by metformin with or without an SGLT2-i for 52 weeks ( In the 52-week SURPASS-4 trial TZP was tested versus insulin glargine in diabetic adults and a high CV risk below not sufficient GC at baseline and in therapy with one to three oral glucose-lowering drugs (metformin, sulfonylurea, SGLT2-i)
Its quick and typically painless, and you can even do it at home
Vital Sign Check : Blood pressure, BMI, metabolic factors, and other key health indicators
Vanderpump MP
